Skip to content

J Psychiatr Res

ISSN 0022-3956; 1879-1379;

6 papers in the library · 10 citations · publishing 1996-2026

Papers

Sort Most recent Most cited

New treatments for OCD? Evidence for cannabinoids and psychedelics.

J Psychiatr Res November 26, 2025 Michael van Ameringen, Vidhi Patel, Beth Patterson et al.

The etiology of OCD is complex and appears to involve multiple biological pathways. Imbalances in central serotonin, dopamine, and glutamate activities are widely thought to play a causative role. Despite strong evidence supporting first-line OCD pharmacotherapies, approximately 40-60 % of OCD patients remain unresponsive and are considered treatment resistant (TR). Although a range of agents...

Associations between psychedelic-related and meditation-related variables: A longitudinal study.

J Psychiatr Res March 17, 2025 Otto Simonsson, Sankalp Chaturvedi, Peter S. Hendricks et al. 2 citations

Previous research has investigated associations between psychedelic experiences and meditation practice, but knowledge gaps remain. Using a longitudinal research design with a sample of US residents between 18 and 50 years old (N = 13,012), we investigated associations between psychedelic-related and meditation-related variables. The follow-up survey was completed by 7484 respondents, of whom...

The effects of psychedelic-assisted therapy on illness and death anxiety: A systematic review and meta-analysis.

J Psychiatr Res March 14, 2025 Aron Amaev, Jianmeng Song, Yasaman Kambari et al. 8 citations

Illness anxiety (IA) is characterized by worry or fear in response to living with a chronic illness or a preoccupation with having or acquiring a serious disease in conjunction with absent to mild somatic symptomatology. Death anxiety (DA) may underpin IA and is more common in individuals with life-threatening illness. Treatments for DA and IA, such as psychotherapy and antidepressant drugs,...